{"count": 27, "results": [{"_id": "33330044", "pmid": 33330044, "pmcid": "PMC7735195", "title": "Nuclear Magnetic Resonance-Based Metabolomic Analysis of the Anticancer Effect of Metformin Treatment on Cholangiocarcinoma Cells", "journal": "Front Oncol", "authors": ["Zhang J", "Hang C", "Jiang T", "Yi S", "Shao W", "Li W", "Lin D"], "date": "2020-11-30T00:00:00Z", "doi": "10.3389/fonc.2020.570516", "meta_date_publication": "2020", "meta_volume": "10", "meta_issue": "", "meta_pages": "570516", "score": 50293.5, "text_hl": "Nuclear Magnetic Resonance-Based Metabolomic Analysis of the Anticancer Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Treatment on @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@Cholangiocarcinoma@@@ Cells", "citations": {"NLM": "Zhang J, Hang C, Jiang T, Yi S, Shao W, Li W, Lin D. Nuclear Magnetic Resonance-Based Metabolomic Analysis of the Anticancer Effect of Metformin Treatment on Cholangiocarcinoma Cells Front Oncol. 2020;10():570516. PMID: 33330044", "BibTeX": "@article{33330044, title={Nuclear Magnetic Resonance-Based Metabolomic Analysis of the Anticancer Effect of Metformin Treatment on Cholangiocarcinoma Cells}, author={Zhang J and Hang C and Jiang T and Yi S and Shao W and Li W and Lin D}, journal={Front Oncol}, volume={10}, pages={570516}}"}}, {"_id": "34745255", "pmid": 34745255, "pmcid": "PMC8570903", "title": "Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China", "journal": "Gastroenterol Res Pract", "authors": ["Wu J", "Zhou Y", "Wang G"], "date": "2021-10-29T00:00:00Z", "doi": "10.1155/2021/9468227", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "9468227", "score": 50287.508, "text_hl": "... @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can improve the survival of advanced @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@EHCC@@@ @SPECIES_9606 @@@patients@@@ who underwent drainage treatment, especially for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use after diagnosis of advanced @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@EHCC@@@ and long duration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Wu J, Zhou Y, Wang G. Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China Gastroenterol Res Pract. 2021;2021():9468227. PMID: 34745255", "BibTeX": "@article{34745255, title={Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China}, author={Wu J and Zhou Y and Wang G}, journal={Gastroenterol Res Pract}, volume={2021}, pages={9468227}}"}}, {"_id": "33380657", "pmid": 33380657, "title": "Decreased risk of cholangiocarcinoma in diabetic patients treated with metformin.", "journal": "J Cancer Res Ther", "authors": ["Sookaromdee P", "Wiwanitkit V"], "date": "2020-12-01T00:00:00Z", "doi": "10.4103/jcrt.JCRT_368_18", "meta_date_publication": "2020 Dec", "meta_volume": "16", "meta_issue": "Supplement", "meta_pages": "S82-S83", "score": 50268.297, "text_hl": "Decreased risk of @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@cholangiocarcinoma@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Sookaromdee P, Wiwanitkit V. Decreased risk of cholangiocarcinoma in diabetic patients treated with metformin. J Cancer Res Ther. 2020 Dec;16(Supplement):S82-S83. PMID: 33380657", "BibTeX": "@article{33380657, title={Decreased risk of cholangiocarcinoma in diabetic patients treated with metformin.}, author={Sookaromdee P and Wiwanitkit V}, journal={J Cancer Res Ther}, volume={16}, number={Supplement}, pages={S82-S83}}"}}, {"_id": "33626532", "pmid": 33626532, "title": "Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.", "journal": "Oncology", "authors": ["Casadei-Gardini A", "Filippi R", "Rimini M", "Rapposelli IG", "Fornaro L", "Silvestris N", "Aldrighetti L", "Aimar G", "Rovesti G", "Bartolini G", "Vivaldi C", "Brunetti O", "Sperti E", "La Face R", "Ratti F", "Andrikou K", "Valgiusti M", "Bernardini L", "Argentiero A", "Fenocchio E", "Frassineti GL", "Cesario S", "Giovannelli F", "Quarà V", "Leone F", "Cascinu S"], "date": "2021-01-01T00:00:00Z", "doi": "10.1159/000512796", "meta_date_publication": "2021", "meta_volume": "99", "meta_issue": "5", "meta_pages": "292-299", "score": 50266.375, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Vitamin_D @CHEMICAL_MESH:D014807 @@@Vitamin D@@@ on Clinical Outcome in @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@Cholangiocarcinoma@@@ @SPECIES_9606 @@@Patients@@@.", "citations": {"NLM": "Casadei-Gardini A, Filippi R, Rimini M, Rapposelli IG, Fornaro L, Silvestris N, Aldrighetti L, Aimar G, Rovesti G, Bartolini G, Vivaldi C, Brunetti O, Sperti E, La Face R, Ratti F, Andrikou K, Valgiusti M, Bernardini L, Argentiero A, Fenocchio E, Frassineti GL, Cesario S, Giovannelli F, Quarà V, Leone F, Cascinu S. Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients. Oncology. 2021;99(5):292-299. PMID: 33626532", "BibTeX": "@article{33626532, title={Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.}, author={Casadei-Gardini A and Filippi R and Rimini M and Rapposelli IG and Fornaro L and Silvestris N and Aldrighetti L and Aimar G and Rovesti G and Bartolini G and Vivaldi C and Brunetti O and Sperti E and La Face R and Ratti F and Andrikou K and Valgiusti M and Bernardini L and Argentiero A and Fenocchio E and Frassineti GL and Cesario S and Giovannelli F and Quarà V and Leone F and Cascinu S}, journal={Oncology}, volume={99}, number={5}, pages={292-299}}"}}, {"_id": "39309781", "pmid": 39309781, "title": "Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learning.", "journal": "Heliyon", "authors": ["Li C", "Deng Y", "Pan Y", "Liao X", "Xie H", "Xue X", "Yu S", "Yu W", "Yu G"], "date": "2024-09-07T00:00:00Z", "doi": "10.1016/j.heliyon.2024.e37347", "meta_date_publication": "2024 Sep 30", "meta_volume": "10", "meta_issue": "18", "meta_pages": "e37347", "score": 50263.69, "text_hl": "Here, we explored the efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the primary prevention of cholangiofibrosis, which can precede the carcinogen-induced development of @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@cholangiocarcinoma@@@ (@<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@CCA@@@). ", "citations": {"NLM": "Li C, Deng Y, Pan Y, Liao X, Xie H, Xue X, Yu S, Yu W, Yu G. Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learning. Heliyon. 2024 Sep 30;10(18):e37347. PMID: 39309781", "BibTeX": "@article{39309781, title={Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learning.}, author={Li C and Deng Y and Pan Y and Liao X and Xie H and Xue X and Yu S and Yu W and Yu G}, journal={Heliyon}, volume={10}, number={18}, pages={e37347}}"}}, {"_id": "36708293", "pmid": 36708293, "title": "Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis.", "journal": "Eur J Gastroenterol Hepatol", "authors": ["Laffusa A", "Ciaccio A", "Elvevi A", "Gallo C", "Ratti L", "Invernizzi P", "Massironi S"], "date": "2023-03-01T00:00:00Z", "doi": "10.1097/MEG.0000000000002503", "meta_date_publication": "2023 Mar 1", "meta_volume": "35", "meta_issue": "3", "meta_pages": "241-247", "score": 50260.53, "text_hl": "We performed this meta-analysis to investigate the role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a potential protective factor for @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@CCA@@@. ", "citations": {"NLM": "Laffusa A, Ciaccio A, Elvevi A, Gallo C, Ratti L, Invernizzi P, Massironi S. Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2023 Mar 1;35(3):241-247. PMID: 36708293", "BibTeX": "@article{36708293, title={Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis.}, author={Laffusa A and Ciaccio A and Elvevi A and Gallo C and Ratti L and Invernizzi P and Massironi S}, journal={Eur J Gastroenterol Hepatol}, volume={35}, number={3}, pages={241-247}}"}}, {"_id": "34069550", "pmid": 34069550, "pmcid": "PMC8161333", "title": "A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid Tumors", "journal": "Cancers (Basel)", "authors": ["Khurshed M", "Molenaar RJ", "van Linde ME", "Mathôt RA", "Struys EA", "van Wezel T", "van Noorden CJF", "Klümpen HJ", "Bovée JVMG", "Wilmink JW"], "date": "2021-05-19T00:00:00Z", "doi": "10.3390/cancers13102474", "meta_date_publication": "2021 May 19", "meta_volume": "13", "meta_issue": "10", "meta_pages": "", "score": 50260.453, "text_hl": "Methods: @SPECIES_9606 @@@Patients@@@ with IDH1-mutated @DISEASE_Chondrosarcoma @DISEASE_MESH:D002813 @@@chondrosarcoma@@@, @DISEASE_Glioma @DISEASE_MESH:D005910 @@@glioma@@@ and @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@intrahepatic cholangiocarcinoma@@@ received oral combinational treatment with the antidiabetic drug @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and the antimalarial drug @CHEMICAL_Chloroquine @CHEMICAL_MESH:D002738 @@@chloroquine@@@. ", "citations": {"NLM": "Khurshed M, Molenaar RJ, van Linde ME, Mathôt RA, Struys EA, van Wezel T, van Noorden CJF, Klümpen HJ, Bovée JVMG, Wilmink JW. A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid Tumors Cancers (Basel). 2021 May 19;13(10):. PMID: 34069550", "BibTeX": "@article{34069550, title={A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid Tumors}, author={Khurshed M and Molenaar RJ and van Linde ME and Mathôt RA and Struys EA and van Wezel T and van Noorden CJF and Klümpen HJ and Bovée JVMG and Wilmink JW}, journal={Cancers (Basel)}, volume={13}, number={10}}"}}, {"_id": "33218924", "pmid": 33218924, "title": "Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication.", "journal": "Can J Diabetes", "authors": ["Saengboonmee C", "Seubwai W", "Lert-Itthiporn W", "Sanlung T", "Wongkham S"], "date": "2021-04-01T00:00:00Z", "doi": "10.1016/j.jcjd.2020.09.008", "meta_date_publication": "2021 Apr", "meta_volume": "45", "meta_issue": "3", "meta_pages": "282-290", "score": 50260.406, "text_hl": "In contrast, @CHEMICAL_Biguanides @CHEMICAL_MESH:D001645 @@@biguanides@@@, especially @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, exert an opposite effect, associated with a reduced risk of @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@CCA@@@ and inhibited in vitro and in vivo @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@CCA@@@ progression. ", "citations": {"NLM": "Saengboonmee C, Seubwai W, Lert-Itthiporn W, Sanlung T, Wongkham S. Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication. Can J Diabetes. 2021 Apr;45(3):282-290. PMID: 33218924", "BibTeX": "@article{33218924, title={Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication.}, author={Saengboonmee C and Seubwai W and Lert-Itthiporn W and Sanlung T and Wongkham S}, journal={Can J Diabetes}, volume={45}, number={3}, pages={282-290}}"}}, {"_id": "38170336", "pmid": 38170336, "title": "Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis.", "journal": "Dig Dis Sci", "authors": ["Deng H", "Qian X", "Zhang Y", "Yu W", "Yang P"], "date": "2024-01-03T00:00:00Z", "doi": "10.1007/s10620-023-08210-x", "meta_date_publication": "2024 Jan 3", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50259.914, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Increases the Response of @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@Cholangiocarcinoma@@@ Cells to @CHEMICAL_Gemcitabine @CHEMICAL_MESH:D000093542 @@@Gemcitabine@@@ by Suppressing @GENE_PKM @GENE_5315 @@@Pyruvate Kinase M2@@@ to Activate Mitochondrial Apoptosis.", "citations": {"NLM": "Deng H, Qian X, Zhang Y, Yu W, Yang P. Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis. Dig Dis Sci. 2024 Jan 3;():. PMID: 38170336", "BibTeX": "@article{38170336, title={Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis.}, author={Deng H and Qian X and Zhang Y and Yu W and Yang P}, journal={Dig Dis Sci}}"}}, {"_id": "38299294", "pmid": 38299294, "title": "Advance of Metformin in Liver Disease.", "journal": "Curr Med Chem", "authors": ["Bao J", "Zhao Y", "Xu X", "Ling S"], "date": "2024-01-30T00:00:00Z", "doi": "10.2174/0109298673274268231215110330", "meta_date_publication": "2024 Jan 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50259.41, "text_hl": "Therefore, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has been found to alleviate @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@nonalcoholic fatty liver disease@@@ and @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@cirrhosis@@@, relieve @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@liver damage@@@, and reduce the incidence of @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@hepatocellular carcinoma@@@ and @<m>DISEASE_Cholangiocarcinoma</m> @DISEASE_MESH:D018281 @@@cholangiocarcinoma@@@. ", "citations": {"NLM": "Bao J, Zhao Y, Xu X, Ling S. Advance of Metformin in Liver Disease. Curr Med Chem. 2024 Jan 30;():. PMID: 38299294", "BibTeX": "@article{38299294, title={Advance of Metformin in Liver Disease.}, author={Bao J and Zhao Y and Xu X and Ling S}, journal={Curr Med Chem}}"}}]}